undifferentiated leukemia

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

Active, not recruiting
  • Acute Myeloid Leukemia
  • +17 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)

Terminated
  • Acute Lymphoblastic Leukemia
  • +17 more
  • Infusion of Treg
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Sep 8, 2020

AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)

Completed
  • AML
  • +11 more
  • Boston, Massachusetts
    Boston Children's Hospital
Oct 31, 2019